{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:38:17Z","timestamp":1782916697870,"version":"3.54.5"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11606-020-05731-3","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:02:43Z","timestamp":1583870563000},"page":"1849-1860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Thiazide Diuretic\u2013Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8973-1667","authenticated-orcid":false,"given":"Jill J.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean T.","family":"Eurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tjosvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Michael","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"issue":"5","key":"5731_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cjca.2018.02.022","volume":"34","author":"KA Nerenberg","year":"2018","unstructured":"Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada\u2019s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34(5):506\u2013525. doi:https:\/\/doi.org\/10.1016\/j.cjca.2018.02.022","journal-title":"Can J Cardiol."},{"issue":"5","key":"5731_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507\u2013520. doi:https:\/\/doi.org\/10.1001\/jama.2013.284427","journal-title":"JAMA."},{"issue":"1","key":"5731_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1161\/HYPERTENSIONAHA.108.114389","volume":"52","author":"BL Carter","year":"2008","unstructured":"Carter BL, Einhorn PT, Brands M, et al. Thiazide-induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008;52(1):30\u201336. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.114389","journal-title":"Hypertension."},{"issue":"5","key":"5731_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.112.192542","volume":"59","author":"WJ Elliott","year":"2012","unstructured":"Elliott WJ. Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: New data on an old topic. Hypertension. 2012;59(5):911\u2013912. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.192542","journal-title":"Hypertension."},{"issue":"6","key":"5731_CR5","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/HYPERTENSIONAHA.108.119404","volume":"52","author":"JW Eriksson","year":"2008","unstructured":"Eriksson JW, Jansson PA, Carlberg B, et al. Hydrochlorothiazide, but not candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) study. Hypertension. 2008;52(6):1030\u20131037. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.119404","journal-title":"Hypertension."},{"issue":"6","key":"5731_CR6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1586\/erc.10.27","volume":"8","author":"JD Duarte","year":"2010","unstructured":"Duarte JD, Cooper-Dehoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther. 2010;8(6):793\u2013802.","journal-title":"Expert Rev Cardiovasc Ther."},{"issue":"2","key":"5731_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","volume":"48","author":"AJ Zillich","year":"2006","unstructured":"Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: A quantitative review. Hypertension. 2006;48(2):219\u2013224. doi:https:\/\/doi.org\/10.1161\/01.HYP.0000231552.10054.aa","journal-title":"Hypertension."},{"issue":"10","key":"5731_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1592\/phco.29.10.1157","volume":"29","author":"SM Smith","year":"2009","unstructured":"Smith SM, Anderson SD, Wen S, et al. Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study. Pharmacotherapy. 2009;29(10):1157\u20131165. doi:https:\/\/doi.org\/10.1592\/phco.29.10.1157","journal-title":"Pharmacotherapy."},{"issue":"6","key":"5731_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1185\/030079907X188044","volume":"23","author":"EL Kuti","year":"2007","unstructured":"Kuti EL, Baker WL, White CM. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Curr Med Res Opin. 2007;23(6):1239\u20131244. doi:https:\/\/doi.org\/10.1185\/030079907X188044","journal-title":"Curr Med Res Opin."},{"issue":"10","key":"5731_CR10","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1097\/01.hjh.0000177537.91527.09","volume":"23","author":"JM Mason","year":"2005","unstructured":"Mason JM, Dickinson HO, Nicolson DJ, Campbell F, Ford GA, Williams B. The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens. 2005;23(10):1777\u20131781.","journal-title":"J Hypertens."},{"issue":"9557","key":"5731_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","volume":"369","author":"WJ Elliott","year":"2007","unstructured":"Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369(9557):201\u2013207. doi:https:\/\/doi.org\/10.1016\/S0140-6736(07)60108-1","journal-title":"Lancet."},{"key":"5731_CR12","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, John PA. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ Online 2009;339:b2700. doi:https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ Online"},{"issue":"2","key":"5731_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison A, Polisena J, Husereau D, et al. The effect of English-language restriction on systematic review-based meta-analyses: A systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(2):138\u2013144. doi:https:\/\/doi.org\/10.1017\/S0266462312000086","journal-title":"Int J Technol Assess Health Care."},{"issue":"9","key":"5731_CR14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0895-4356(00)00188-8","volume":"53","author":"D Moher","year":"2000","unstructured":"Moher D, Pham B, Klassen TP, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000;53(9):964\u2013972. doi:https:\/\/doi.org\/10.1016\/S0895-4356(00)00188-8","journal-title":"J Clin Epidemiol."},{"key":"5731_CR15","unstructured":"Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.1 [Updated March 2011]. The Cochrane Collaboration, 2011. www.handbook.cochrane.org."},{"issue":"11","key":"5731_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.7326\/M15-2650","volume":"164","author":"NM Maruthur","year":"2016","unstructured":"Maruthur NM, Tseng E, Hutfless S, et al. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: A systematic review and meta-analysis. Ann Intern Med. 2016;164(11):740\u2013751. doi:https:\/\/doi.org\/10.7326\/M15-2650","journal-title":"Ann Intern Med."},{"issue":"5","key":"5731_CR17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1742-1241.1997.tb11458.x","volume":"51","author":"J Fodor","year":"1997","unstructured":"Fodor J. Comparative efficacy and tolerability of nisoldipine coat core and hydrochlorothiazide in mild-to-moderate hypertension. Int J Clin Pract. 1997;51(5):271\u2013275.","journal-title":"Int J Clin Pract."},{"key":"5731_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ctcp.2012.02.002","volume":"18","author":"AFG Cicero","year":"2012","unstructured":"Cicero AFG, De Sando V, Izzo R, Vasta A, Trimarco A, Borghi C. Effect of a combined nutraceutical containing Orthosiphon stamineus effect on blood pressure and metabolic syndrome components in hypertensive dyslipidaemic patients: A randomized clinical trial. Complement Ther Clin Pract. 2012;18:190\u2013194. doi:https:\/\/doi.org\/10.1016\/j.ctcp.2012.02.002","journal-title":"Complement Ther Clin Pract."},{"issue":"2","key":"5731_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1753944716678538","volume":"11","author":"AF Rubio-Guerra","year":"2017","unstructured":"Rubio-Guerra AF, Garro-Almendaro AK, Elizalde-Barrera CI, Suarez-Cuenca JA, Duran-Salgado MB. Effect of losartan combined with amlodipine or with a thiazide on uric acid levels in hypertensive patients. Ther Adv Cardiovasc Dis. 2017;11(2):57\u201362. doi:https:\/\/doi.org\/10.1177\/1753944716678538","journal-title":"Ther Adv Cardiovasc Dis."},{"issue":"23","key":"5731_CR20","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"\u201cThe ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.\u201d Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic. JAMA. 2002;288(23):2981\u20132196. http:\/\/jama.jamanetwork.com\/.","journal-title":"JAMA."},{"issue":"1","key":"5731_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jacc.2010.02.046","volume":"56","author":"MA Weber","year":"2010","unstructured":"Weber MA, Bakris GL, Jamerson K, et al. Cardiovascular Events During Differing Hypertension Therapies in Patients With Diabetes. J Am Coll Cardiol. 2010;56(1):77\u201385. doi:https:\/\/doi.org\/10.1016\/j.jacc.2010.02.046","journal-title":"J Am Coll Cardiol."},{"key":"5731_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/pgmj.62.732.919","volume":"62","author":"A Amery","year":"1986","unstructured":"Amery A, Birkenh\u00e4ger W, Brixko P, et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE). Postgrad Med J. 1986;62:919\u2013924. doi:https:\/\/doi.org\/10.1136\/pgmj.62.732.919","journal-title":"Postgrad Med J."},{"key":"5731_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archinte.1994.00420070047005","volume":"154","author":"S Chrysant","year":"1994","unstructured":"Chrysant S, \u201cThe Lisinopril-Hydrochlorothiazide Group.\u201d Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination: a large multicenter study. Arch Intern Med. 1994;154:737\u2013743.","journal-title":"Arch Intern Med."},{"issue":"1","key":"5731_CR24","first-page":"94","volume":"11","author":"P Maroko","year":"1989","unstructured":"Maroko P, McDevitt J, Fox M, et al. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG trial. Clin Ther. 1989;11(1):94\u2013119.","journal-title":"Clin Ther."},{"issue":"5","key":"5731_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/j.1875-9114.1993.tb04312.x","volume":"13","author":"PE Pool","year":"1993","unstructured":"Pool PE, Applegate WB, Woehler T, Sandall P, Cady WJ. A Randomized, Controlled Trial Comparing Diltiazem, Hydrochlorothiazide, and Their Combination in the Therapy of Essential Hypertension. Pharmacotherapy. 1993;13(5):487\u2013493. doi:https:\/\/doi.org\/10.1002\/j.1875-9114.1993.tb04312.x","journal-title":"Pharmacotherapy."},{"key":"5731_CR26","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0002-9343(00)00510-6","volume":"109","author":"IR Reid","year":"2000","unstructured":"Reid IR, Ames RW, Orr-Walker BJ, et al. Hydrochlorothiazide Reduces Loss of Cortical Bone in Normal Postmenopausal Women: A Randomized Controlled Trial. Am J Med. 2000;109:362\u2013370.","journal-title":"Am J Med."},{"key":"5731_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/archinte.158.7.741","volume":"158","author":"PJ Savage","year":"1998","unstructured":"Savage PJ, Pressel SL, Curb JD, et al. Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension The Systolic Hypertension in the Elderly Program. Arch Intern Med. 1998;158:741\u2013751. http:\/\/archinte.jamanetwork.com\/.","journal-title":"Arch Intern Med."},{"key":"5731_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1161\/01.hyp.23.6.688","volume":"23","author":"D Siegel","year":"1994","unstructured":"Siegel D, Saliba P, Haffner S. Glucose and insulin levels during diuretic therapy in hypertensive men. Hypertension. 1994;23:688\u2013694. doi:https:\/\/doi.org\/10.1161\/01.hyp.23.6.688","journal-title":"Hypertension."},{"key":"5731_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12872-016-0368-2","volume":"16","author":"DJ Damian","year":"2016","unstructured":"Damian DJ, McNamee R, Carr M. Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial. BMC Cardiovasc Disord. 2016;16:188. doi:https:\/\/doi.org\/10.1186\/s12872-016-0368-2","journal-title":"BMC Cardiovasc Disord."},{"key":"5731_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.jhh.1000419","volume":"11","author":"R Fiddes","year":"1997","unstructured":"Fiddes R, Blumenthal J, Dawson JE, et al. Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension. J Hum Hypertens. 1997;11:239\u2013244. doi:https:\/\/doi.org\/10.1038\/sj.jhh.1000419","journal-title":"J Hum Hypertens."},{"issue":"15","key":"5731_CR31","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1001\/jama.1980.03310150027023","volume":"224","author":"AI Goldman","year":"1980","unstructured":"Goldman AI, Steele BW, Schaper HW, Fitz AE, Frohlich ED, Perry HMJ. Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute Cooperative Study on Antihypertensive Therapy: Mild Hypertension. JAMA. 1980;224(15):1691\u20131695.","journal-title":"JAMA."},{"key":"5731_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1109\/NBiS.2011.113","volume":"94","author":"RH Grimm","year":"1981","unstructured":"Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. A double-blind controlled trial. Ann Intern Med. 1981;94:7\u201311. doi:https:\/\/doi.org\/10.1109\/NBiS.2011.113","journal-title":"Ann Intern Med."},{"key":"5731_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/08037059409102262","volume":"3","author":"AJ Jounela","year":"1994","unstructured":"Jounela AJ, Lilja M, Lumme J, et al. Relation Between Low Dose of Hydrochlorothiazide, Antihypertensive Effect and Adverse Effects. Blood Press. 1994;3:231\u2013235.","journal-title":"Blood Press."},{"key":"5731_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2008.11.017","volume":"140","author":"KK Koh","year":"2010","unstructured":"Koh KK, Quon MJ, Han SH, et al. Distinct vascular and metabolic effects of different classes of antihypertensive drugs. Int J Cardiol. 2010;140:73\u201381.","journal-title":"Int J Cardiol."},{"key":"5731_CR35","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/dom.12127","volume":"15","author":"HJ Lambers Heerspink","year":"2013","unstructured":"Lambers Heerspink HJ, De Zeeuw D, Wie L, Leslie B, List J. Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes. Diabetes, Obes Metab. 2013;15:853\u2013862. doi:https:\/\/doi.org\/10.1111\/dom.12127","journal-title":"Diabetes, Obes Metab."},{"issue":"9","key":"5731_CR36","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/j.1742-1241.2010.02412.x","volume":"64","author":"F Malekzadeh","year":"2010","unstructured":"Malekzadeh F, Marshall T, Pourshas A, et al. A pilot double-blind randomised placebo controlled trial of the effects of fixed-dose combination therapy (\u2018polypill\u2019) on cardiovascular risk factors. Int J Clin Pract. 2010;64(9):1120\u20131227. doi:https:\/\/doi.org\/10.1111\/j.1742-1241.2010.02412.x","journal-title":"Int J Clin Pract."},{"key":"5731_CR37","doi-asserted-by":"crossref","unstructured":"Berglund G, Andersson O. Beta-blockers or diuretics in hypertension? A six-year follow-up of blood pressure and metabolic side effects. Lancet. 1981:744\u2013747.","DOI":"10.1016\/S0140-6736(81)92624-6"},{"issue":"3","key":"5731_CR38","first-page":"522","volume":"36","author":"E Bichisao","year":"1984","unstructured":"Bichisao E, Pollavini G, Alberti D, Baroni L, Cortellaro M. Slow-release metoprolol and chlorthalidone in the management of arterial hypertension: a multicentre study. Curr Ther Res. 1984;36(3):522\u2013529.","journal-title":"Curr Ther Res."},{"issue":"4","key":"5731_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.20452\/pamw.3390","volume":"126","author":"A Skoczylas","year":"2016","unstructured":"Skoczylas A, Piecha G, Wi\u0229cek A. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations. Pol Arch Med Wewn. 2016;126(4):243\u2013253. doi:https:\/\/doi.org\/10.20452\/pamw.3390","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"5731_CR40","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ajh.2011.215","volume":"25","author":"SM Smith","year":"2012","unstructured":"Smith SM, Gong Y, Turner ST, et al. Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol. Am J Hypertens. 2012;25(3):359\u2013365. doi:https:\/\/doi.org\/10.1038\/ajh.2011.215","journal-title":"Am J Hypertens."},{"issue":"11","key":"5731_CR41","first-page":"696","volume":"70","author":"G Yonga","year":"1993","unstructured":"Yonga G, Ogola E, Orinda D. Metabolic effects of propranolol and hydroflumethiazide treatment in Kenyans with mild to moderate hypertension. East Afr Med J. 1993;70(11):696.","journal-title":"East Afr Med J."},{"key":"5731_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2125.1995.tb04482.x","volume":"39","author":"R Fogari","year":"1995","unstructured":"Fogari R, Zoppi A, Malamani G, Marasi G, Vanasia A, Villa G. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. Br J Clin Pharmacol. 1995;39:471\u2013476. doi:https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb04482.x","journal-title":"Br J Clin Pharmacol."},{"key":"5731_CR43","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/0002-9149(83)90579-9","volume":"52","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1983","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension. Am J Cardiol. 1983;52:1230\u20131237.","journal-title":"Am J Cardiol."},{"key":"5731_CR44","first-page":"298","volume":"6","author":"H Milon","year":"1984","unstructured":"Milon H, Froment A, Gaspard P, Delahaye J. Treatment of arterial hypertension: A comparative trial of atenolol versus chlorthalidone. Clin Trials J. 1984;6:298\u2013307.","journal-title":"Clin Trials J."},{"key":"5731_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2796.1990.tb00240.x","volume":"228","author":"J Monmany","year":"1990","unstructured":"Monmany J, Djomingo P, Gomez JA, et al. Effects of long-term treatment with metoprolol and hydrochlorothiazide on plasma lipids and lipoproteins. J Intern Med. 1990;228:323\u2013331. doi:https:\/\/doi.org\/10.1111\/j.1365-2796.1990.tb00240.x","journal-title":"J Intern Med."},{"key":"5731_CR46","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0895-7061(97)00110-6","volume":"10","author":"I Os","year":"1997","unstructured":"Os I, Hotnes T, Dollerup J, Mogensen CE. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to moderate hypertension. Am J Hypertens. 1997;10:889\u2013904. doi:https:\/\/doi.org\/10.1016\/S0895-7061(97)00110-6","journal-title":"Am J Hypertens."},{"issue":"3","key":"5731_CR47","first-page":"467","volume":"35","author":"G Pollavini","year":"1984","unstructured":"Pollavini G, Comi D, Grillo C, et al. Multicentre randomized cross-over double-blind comparison between chlorthalidone and slow-release oxprenolol in mild-to-moderate hypertension. Curr Ther Res. 1984;35(3):467\u2013475.","journal-title":"Curr Ther Res."},{"issue":"4","key":"5731_CR48","doi-asserted-by":"publisher","first-page":"760","DOI":"10.5114\/aoms.2016.58825","volume":"13","author":"M Rajzer","year":"2017","unstructured":"Rajzer M, Wojciechowska W, Kameczura T, et al. The effect of antihypertensive treatment on arterial stiffness & serum concentration of selected matrix metalloproteinases. Arch Med Sci. 2017;13(4):760\u2013770. doi:https:\/\/doi.org\/10.5114\/aoms.2016.58825","journal-title":"Arch Med Sci."},{"issue":"6","key":"5731_CR49","first-page":"1008","volume":"7","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1985","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents. Propranolol or hydrochlorothiazide alone for the initial treatment of hypertension: IV. Effect on Plasma Glucose and Glucose Tolerance. Hypertension. 1985;7(6):1008\u20131016.","journal-title":"Hypertension"},{"issue":"2","key":"5731_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00044011-200626020-00004","volume":"26","author":"S Rasmussen","year":"2006","unstructured":"Rasmussen S, Borrild N, Vang Andersen J. Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg\/day or 2.5 mg\/day and potassium chloride compared with enalapril 10 mg\/day and amlodipine 5 mg\/day in patients with mild to moderate primary hypertension a multicentre, randomized, open study. Clin Drug Investig. 2006;26(2):91\u2013101. doi:https:\/\/doi.org\/10.2165\/00044011-200626020-00004","journal-title":"Clin Drug Investig."},{"key":"5731_CR51","doi-asserted-by":"publisher","unstructured":"Takihata M, Nakamura A, Kondo Y, Kawasaki S, Kimura M, Terauchi Y. Comparison of azelnidipine and trichlormethiazide in Japanese type 2 diabetic patients with hypertension:The COAT randomized controlled trial. PLoS One. 2015. doi:https:\/\/doi.org\/10.1371\/journal.pone.0125519","DOI":"10.1371\/journal.pone.0125519"},{"issue":"3","key":"5731_CR52","doi-asserted-by":"publisher","first-page":"550","DOI":"10.5114\/aoms.2016.62448","volume":"13","author":"D Bosone","year":"2017","unstructured":"Bosone D, Costa A, Ghiotto N, et al. Effect of ramipril\/hydrochlorothiazide and ramipril\/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy. Arch Med Sci. 2017;13(3):550\u2013557. doi:https:\/\/doi.org\/10.5114\/aoms.2016.62448","journal-title":"Arch Med Sci."},{"key":"5731_CR53","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2337\/diacare.21.12.2103","volume":"21","author":"RP Byington","year":"1998","unstructured":"Byington RP, Furberg CD, Craven TE, Pahor M, Sowers JR. Isradipine in Prediabetic Hypertensive Subjects. Diabetes Care. 1998;21:2103\u20132110.","journal-title":"Diabetes Care."},{"issue":"5","key":"5731_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2165\/00044011-200019050-00001","volume":"19","author":"C Calvo","year":"2000","unstructured":"Calvo C, Gude F, Abell\u00e1n J, et al. A comparative evaluation of amlodipine and hydrochlorothiazide as monotherapy in the treatment of isolated systolic hypertension in the elderly. Clin Drug Investig. 2000;19(5):317\u2013326. doi:https:\/\/doi.org\/10.2165\/00044011-200019050-00001","journal-title":"Clin Drug Investig."},{"issue":"17","key":"5731_CR55","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/0002-9149(88)90263-9","volume":"62","author":"D Leehey","year":"1988","unstructured":"Leehey D, Hartman E. Comparison of diltiazem and hydrochlorothiazide for treatment of patients 60 years of age or older with systemic hypertension. Am J Cardiol. 1988;62(17):1218\u20131223.","journal-title":"Am J Cardiol."},{"key":"5731_CR56","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/db14-0670","volume":"64","author":"R Garg","year":"2015","unstructured":"Garg R, Rao AD, Baimas-George M, et al. Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes. 2015;64:236\u2013242. doi:https:\/\/doi.org\/10.2337\/db14-0670","journal-title":"Diabetes."},{"key":"5731_CR57","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/ajh\/7.7.615","volume":"7","author":"A Haenni","year":"1994","unstructured":"Haenni A, Andersson P, Lind L, Berne C, Lithell H. Electrolyte changes and metabolic effects of lisinopril\/bendrofluazide treatment. Results from a randomized, double-blind study with parallel groups. Am J Hypertens. 1994;7:615\u2013622.","journal-title":"Am J Hypertens."},{"key":"5731_CR58","first-page":"30","volume":"11","author":"M Lin","year":"1995","unstructured":"Lin M, Yang Y-F, Chiang Derek Lee H-T, Wang S-P, Chang M-S, Cheitlin MD. Beneficial Effects of Angiotensin-Converting Enzyme Inhibitors on Cardiovascular and Renal Functions in Patients with Hypertension and Diabetes. Acta Cardiol Sin. 1995;11:30\u201338.","journal-title":"Acta Cardiol Sin."},{"key":"5731_CR59","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1097\/01.hjh.0000084723.53355.76","volume":"21","author":"LH Lindholm","year":"2003","unstructured":"Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens. 2003;21:1563\u20131574. doi:https:\/\/doi.org\/10.1097\/01.hjh.0000084723.53355.76","journal-title":"J Hypertens."},{"key":"5731_CR60","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/10641960802621259","volume":"31","author":"S Makita","year":"2009","unstructured":"Makita S, Abiko A, Naganuma Y, Tamada M, Nakamura M. Efficacy of low-dose hydrochlorothiazide in combination with telmisartan on early morning blood pressure in uncontrolled hypertensive patients. Clin Exp Hypertens. 2009;31:105\u2013115. doi:https:\/\/doi.org\/10.1080\/10641960802621259","journal-title":"Clin Exp Hypertens."},{"key":"5731_CR61","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/01.hjh.0000133733.32125.09","volume":"22","author":"M Marre","year":"2004","unstructured":"Marre M, Puig JG, Kokot F, et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertenisve patients with type 2 diabetes: the NESTOR study. J Hypertens. 2004;22:1613\u20131622. doi:https:\/\/doi.org\/10.1097\/01.hjh.0000133733.32125.09","journal-title":"J Hypertens."},{"issue":"8","key":"5731_CR62","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3109\/10641963.2013.776564","volume":"35","author":"H Nishimura","year":"2013","unstructured":"Nishimura H, Shintani M, Maeda K, et al. Which is a better treatment for hypertensive patients with diabetes: A combination of losartan and hydrochlorothiazide or a maximum dose of Losartan? Clin Exp Hypertens. 2013;35(8):582\u2013588. doi:https:\/\/doi.org\/10.3109\/10641963.2013.776564","journal-title":"Clin Exp Hypertens."},{"issue":"13","key":"5731_CR63","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJM198909283211305","volume":"321","author":"T Pollare","year":"1989","unstructured":"Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321(13):868\u2013873.","journal-title":"N Engl J Med."},{"issue":"4","key":"5731_CR64","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0895-7061(97)00492-5","volume":"11","author":"M Roman","year":"1998","unstructured":"Roman M, Alderman M, Pickering T, et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure. Am J Hypertens. 1998;11(4):387\u2013396.","journal-title":"Am J Hypertens."},{"issue":"2","key":"5731_CR65","first-page":"63","volume":"26","author":"T Rosenthal","year":"1990","unstructured":"Rosenthal T, Grossman E, Rathaus M, et al. Treatment of hypertension by enalapril and hydrochlorothiazide separately and together: a multicenter study. Isr J Med Sci. 1990;26(2):63\u201366.","journal-title":"Isr J Med Sci."},{"issue":"3","key":"5731_CR66","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0011-393X(05)80414-X","volume":"52","author":"M Scali","year":"1992","unstructured":"Scali M, Armanini D, Mantero F, et al. Metabolic effects of lisinopril versus hydrochlorothiazide plus amiloride in essential hypertension. Curr Ther Res. 1992;52(3):397\u2013405. doi:https:\/\/doi.org\/10.1016\/S0011-393X(05)80414-X","journal-title":"Curr Ther Res."},{"issue":"4","key":"5731_CR67","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000006799","volume":"89","author":"M Stimpel","year":"1998","unstructured":"Stimpel M, Koch B, Oparil S. Antihypertensive treatment in postmenopausal women: results from a prospective, randomized, double-blind, controlled study comparing an ACE inhibitor (moexipril) with a diuretic (hydrochlorothiazide). Cardiology. 1998;89(4):271\u2013276.","journal-title":"Cardiology."},{"key":"5731_CR68","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1751-7176.2008.00054.x","volume":"10","author":"DH Zappe","year":"2008","unstructured":"Zappe DH, Sowers JR, Hsueh WA, et al. Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome. J Clin Hypertens. 2008;10:894\u2013903. doi:https:\/\/doi.org\/10.1111\/j.1751-7176.2008.00054.x","journal-title":"J Clin Hypertens"},{"key":"5731_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3109\/08037050903497238","volume":"19","author":"J-L Zhang","year":"2010","unstructured":"Zhang J-L, Qin Y-W, Zheng X, Qiu J-L, Zhao X-X, Zou D-J. Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients. Blood Press. 2010;19:110\u2013118.","journal-title":"Blood Press."},{"issue":"10","key":"5731_CR70","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1097\/HJH.0000000000001407","volume":"35","author":"P Zhang","year":"2017","unstructured":"Zhang P, Wang H, Sun L, et al. Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: A randomized double-blind trial. J Hypertens. 2017;35(10):2077\u20132085. doi:https:\/\/doi.org\/10.1097\/HJH.0000000000001407","journal-title":"J Hypertens."},{"issue":"9","key":"5731_CR71","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1592\/phco.29.9.1061","volume":"29","author":"M Abe","year":"2009","unstructured":"Abe M, Okada K, Maruyama T, Matsumoto K. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease. Pharmacotherapy. 2009;29(9):1061\u20131072.","journal-title":"Pharmacotherapy."},{"issue":"2","key":"5731_CR72","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/ajh.2009.214","volume":"23","author":"SA Brandao","year":"2010","unstructured":"Brandao SA, Izar MC, Fischer SM, et al. Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control. Am J Hypertens. 2010;23(2):208\u2013214.","journal-title":"Am J Hypertens."},{"key":"5731_CR73","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.lfs.2015.10.030","volume":"143","author":"HAR Fonseca","year":"2015","unstructured":"Fonseca HAR, Fonseca FA, Lins LC, et al. Antihypertensive therapy increases natural immunity response in hypertensive patients. Life Sci. 2015;143:124\u2013130. doi:https:\/\/doi.org\/10.1016\/j.lfs.2015.10.030","journal-title":"Life Sci."},{"key":"5731_CR74","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1097\/HJH.0000000000000837","volume":"34","author":"FD Fuchs","year":"2016","unstructured":"Fuchs FD, Scala LCN, Vilela-Martin JF, et al. Effectiveness of chlorthalidone\/amiloride versus losartan in patients with stage I hypertension: Results from the PREVER-treatment randomized trial. J Hypertens. 2016;34:798\u2013806. doi:https:\/\/doi.org\/10.1097\/HJH.0000000000000837","journal-title":"J Hypertens."},{"key":"5731_CR75","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","volume":"4","author":"MJ Brown","year":"2016","unstructured":"Brown MJ, Williams B, Morant S V., et al. Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): A parallel-group, double-blind randomised phase 4 trial. Lancet Diabetes Endocrinol. 2016;4:136\u2013147. doi:https:\/\/doi.org\/10.1016\/S2213-8587(15)00377-0","journal-title":"Lancet Diabetes Endocrinol."},{"key":"5731_CR76","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archinte.1981.00340040078021","volume":"141","author":"Multicenter Diuretic Cooperative Study Group","year":"1981","unstructured":"\u201cMulticenter Diuretic Cooperative Study Group.\u201d Multiclinic Comparison of Amiloride, Hydrochlorothiazide, and Hydrochlorothiazide Plus Amiloride in Essential Hypertension. Arch Intern Med. 1981;141:482\u2013486.","journal-title":"Arch Intern Med"},{"issue":"1","key":"5731_CR77","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1470320313481485","volume":"16","author":"A Momeni","year":"2015","unstructured":"Momeni A, Behradmanesh MS, Kheiri S, Karami Horestani M. Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy. J Renin-Angiotensin-Aldosterone Syst. 2015;16(1):113\u2013118. doi:https:\/\/doi.org\/10.1177\/1470320313481485","journal-title":"J Renin-Angiotensin-Aldosterone Syst."},{"key":"5731_CR78","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3109\/10641960903407017","volume":"31","author":"M Yutaka","year":"2009","unstructured":"Yutaka M, Mifune M, Kubota E, Itoh H, Saito I. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker. Clin Exp Hypertens. 2009;31:648\u2013656. doi:https:\/\/doi.org\/10.3109\/10641960903407017","journal-title":"Clin Exp Hypertens."},{"key":"5731_CR79","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/dom.12486","volume":"17","author":"NB Amin","year":"2015","unstructured":"Amin NB, Wang X, Mitchell JR, Lee DS, Nucci G, Rusnak JM. Blood pressure-lowering effect of the sodium glucose co-transporter-2 inhibitor ertugliflozin, assessed via ambulatory blood pressure monitoring in patients with type 2 diabetes and hypertension. Diabetes, Obes Metab. 2015;17:805\u2013808. doi:https:\/\/doi.org\/10.1111\/dom.12486","journal-title":"Diabetes, Obes Metab."},{"issue":"Suppl. 2","key":"5731_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/08038020310016369","volume":"12","author":"C Campo","year":"2003","unstructured":"Campo C, Segura J, Rold\u00e1n C, Alc\u00e1zar JM, Rodicio JL, Ruilope LM. Doxazosin GITS versus hydrochlorothiazide as addon therapy in patients with uncontrolled hypertension. Blood Press. 2003;12(Suppl. 2):16\u201321. doi:https:\/\/doi.org\/10.1080\/08038020310016369","journal-title":"Blood Press."},{"issue":"3","key":"5731_CR81","first-page":"169","volume":"52","author":"O Charansonney","year":"1997","unstructured":"Charansonney O, Lievre M, Laville M, et al. The EUREVIE Study: Contrasting effect of piretanide and thiazides in mild to moderate hypertension. Therapie. 1997;52(3):169\u2013177.","journal-title":"Therapie."},{"issue":"6","key":"5731_CR82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM197908093010602","volume":"301","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1979","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparative effects of ticrynafen and hydrochlorothiazide in the treatment of hypertension. N Engl J Med. 1979;301(6):293\u2013297.","journal-title":"N Engl J Med."},{"issue":"5","key":"5731_CR83","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/030006058901700504","volume":"17","author":"J Hegbrant","year":"1989","unstructured":"Hegbrant J, Skogstrom K, Mansby J. Comparison of slow-release piretanide and bendroflumethiazide in the treatment of mild to moderate hypertension. J Int Med Res. 1989;17(5):426\u2013434.","journal-title":"J Int Med Res."},{"key":"5731_CR84","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/0002-9343(84)90990-2","volume":"76","author":"A Helgeland","year":"1984","unstructured":"Helgeland A, Leren P, Foss O, Hjermann I, Holme I, Lund-Larsen P. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The OSLO study. Am J Med. 1984;76:802\u2013805.","journal-title":"Am J Med."},{"key":"5731_CR85","first-page":"443","volume":"6","author":"A Obel","year":"1984","unstructured":"Obel A, Griffin L, Were J. Comparison of slow-release frusemide and bendrofluazide in the treatment of moderate hypertension in Kenyan negroes. Clin Trials J. 1984;6:443\u2013450.","journal-title":"Clin Trials J."},{"issue":"7","key":"5731_CR86","doi-asserted-by":"publisher","first-page":"4576","DOI":"10.1136\/bmjopen-2013-004576","volume":"4","author":"S Ueda","year":"2014","unstructured":"Ueda S, Morimoto T, Ando S, et al. A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study. BMJ Open. 2014;4(7):4576\u20134576. doi:https:\/\/doi.org\/10.1136\/bmjopen-2013-004576","journal-title":"BMJ Open."},{"key":"5731_CR87","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/clpt.1986.92","volume":"39","author":"P Wicker","year":"1986","unstructured":"Wicker P, Clementy J. Comparison of the effects of muzolimine and a fixed combination of diuretics in essential hypertension. Clin Pharmacol Ther. 1986;39:537\u2013542. doi:https:\/\/doi.org\/10.1038\/clpt.1986.92","journal-title":"Clin Pharmacol Ther."},{"key":"5731_CR88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2169\/internalmedicine.47.0449","volume":"47","author":"R Fogari","year":"2008","unstructured":"Fogari R, Derosa G, Zoppi A, et al. Effect of Delapril\/Manidipine vs Olmesartan\/ Hydrochlorothiazide Combination on Insulin Sensitivity and Fibrinogen in Obese Hypertensive Patients. Intern Med. 2008;47:361\u2013366. doi:https:\/\/doi.org\/10.2169\/internalmedicine.47.0449","journal-title":"Intern Med."},{"issue":"4","key":"5731_CR89","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1517\/14656566.2014.874415","volume":"15","author":"R Fogari","year":"2014","unstructured":"Fogari R, Derosa G, Zoppi A, Lazzari P, D\u2019Angelo A, Mugellini A. Comparative effect of canrenone or hydrochlorothiazide addition to valsartan\/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria. Expert Opin Pharmacother. 2014;15(4):453\u2013459. doi:https:\/\/doi.org\/10.1517\/14656566.2014.874415","journal-title":"Expert Opin Pharmacother."},{"key":"5731_CR90","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.vph.2015.06.004","volume":"92","author":"L Ghiadoni","year":"2017","unstructured":"Ghiadoni L, Bruno RM, Cartoni G, et al. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome. Vascul Pharmacol. 2017;92:16\u201321. doi:https:\/\/doi.org\/10.1016\/j.vph.2015.06.004","journal-title":"Vascul Pharmacol."},{"key":"5731_CR91","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0895-7061(03)00062-1","volume":"16","author":"H Holzgreve","year":"2003","unstructured":"Holzgreve H, Nakov R, Beck K, Janka HU. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Am J Hypertens. 2003;16:381\u2013386. doi:https:\/\/doi.org\/10.1016\/S0895-7061(03)00062-1","journal-title":"Am J Hypertens."},{"issue":"7","key":"5731_CR92","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3109\/10641963.2016.1151526","volume":"37","author":"S Karashima","year":"2016","unstructured":"Karashima S, Yoneda T, Kometani M, et al. Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus. Clin Exp Hypertens. 2016;37(7):565\u2013570. doi:https:\/\/doi.org\/10.3109\/10641963.2016.1151526","journal-title":"Clin Exp Hypertens."},{"key":"5731_CR93","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/hr.2010.233","volume":"34","author":"J Kato","year":"2011","unstructured":"Kato J, Yokota N, Tamaki N, et al. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension. Hypertens Res. 2011;34:331\u2013335. doi:https:\/\/doi.org\/10.1038\/hr.2010.233","journal-title":"Hypertens Res."},{"issue":"8","key":"5731_CR94","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.clinthera.2012.06.014","volume":"34","author":"I-T Lee","year":"2012","unstructured":"Lee I-T, Hung Y-J, Chen J-F, Wang C-Y, Lee W-J, Huey-Herng Sheu W. Comparison of the efficacy and safety profiles of two fixed- dose combinations of antihypertensive agents, amlodipine\/benazepril versus valsartan\/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: A 16-week, multicenter, tand. Clin Ther. 2012;34(8):1735\u20131750. doi:https:\/\/doi.org\/10.1016\/j.clinthera.2012.06.014","journal-title":"Clin Ther."},{"key":"5731_CR95","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/jhh.2010.104","volume":"25","author":"FJ Martinez-Martin","year":"2011","unstructured":"Martinez-Martin FJ, Rodriguez-Rosas H, Peiro-Martinez I, Soriano-Perera P, Pedrianes-Martin P, Comi-Diaz C. Olmesartan\/amlodipine vs olmesartan\/hydrochlorothiazide in hypertensive patients with metabolic syndrome: The OLAS study. J Hum Hypertens. 2011;25:346\u2013353. doi:https:\/\/doi.org\/10.1038\/jhh.2010.104","journal-title":"J Hum Hypertens."},{"issue":"4","key":"5731_CR96","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/ajh.2010.240","volume":"24","author":"Y Matsui","year":"2011","unstructured":"Matsui Y, Eguchi K, Ishikawa J, Shimada K, Kario K. Urinary albumin excretion during angiotensin II receptor blockade: Comparison of combination treatment with a diuretic or a calcium-channel blocker. Am J Hypertens. 2011;24(4):466\u2013473. doi:https:\/\/doi.org\/10.1038\/ajh.2010.240","journal-title":"Am J Hypertens."},{"key":"5731_CR97","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.jhh.1001726","volume":"18","author":"A Mugellini","year":"2004","unstructured":"Mugellini A, Preti P, Zoppi A, et al. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus. J Hum Hypertens. 2004;18:687\u2013691. doi:https:\/\/doi.org\/10.1038\/sj.jhh.1001726","journal-title":"J Hum Hypertens."},{"key":"5731_CR98","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/oxfordjournals.qjmed.a068893","volume":"87","author":"S Nielsen","year":"1994","unstructured":"Nielsen S, Schmitz A, Mogensen CE, Knudsen RE, Dollerup J. Enalapril versus bendroflumethiazide in type 2 diabetes complicated by hypertension. QJM. 1994;87:747\u2013754. doi:https:\/\/doi.org\/10.1093\/oxfordjournals.qjmed.a068893","journal-title":"QJM."},{"issue":"4","key":"5731_CR99","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.clinthera.2013.02.021","volume":"35","author":"M Nishiwaki","year":"2013","unstructured":"Nishiwaki M, Hosoai H, Ikewaki K, et al. Efficacy and Effects on Lipid Metabolism of Combination Treatment With Losartan + Hydrochlorothiazide Versus Losartan + Amlodipine: A 48-Week Prospective, Multicenter, Randomized, Open-Label Trial, Clin Ther. 2013;35(4):461\u2013473. doi:https:\/\/doi.org\/10.1016\/j.clinthera.2013.02.021","journal-title":"Clin Ther."},{"issue":"4","key":"5731_CR100","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3109\/10641963.2013.810227","volume":"36","author":"J Oshikawa","year":"2014","unstructured":"Oshikawa J, Toya Y, Morita S, et al. Angiotensin receptor blocker (ARB)-diuretic versus ARB-calcium channel blocker combination therapy for hypertension uncontrolled by ARB monotherapy. Clin Exp Hypertens. 2014;36(4):244\u2013250. doi:https:\/\/doi.org\/10.3109\/10641963.2013.810227","journal-title":"Clin Exp Hypertens."},{"issue":"6","key":"5731_CR101","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1185\/03007990802118071","volume":"24","author":"A Pareek","year":"2008","unstructured":"Pareek A, Karnik N, Salagre SB, et al. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study. Curr Med Res Opin. 2008;24(6):1771\u20131779. doi:https:\/\/doi.org\/10.1185\/03007990802118071","journal-title":"Curr Med Res Opin."},{"key":"5731_CR102","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00392-014-0755-6","volume":"104","author":"A Posadzy-Malaczynska","year":"2014","unstructured":"Posadzy-Malaczynska A, Rajpold K, Woznicka-Leskiewicz L, Marcinkowska J. Hemodynamic and metabolic effects of estrogen plus progestin therapy in hypertensive postmenopausal women treated with an ACE-inhibitor or a diuretic. Clin Res Cardiol. 2014;104:38\u201350. doi:https:\/\/doi.org\/10.1007\/s00392-014-0755-6","journal-title":"Clin Res Cardiol."},{"key":"5731_CR103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/hr.2014.141","volume":"38","author":"T Saruta","year":"2015","unstructured":"Saruta T, Ogihara T, Saito I, et al. Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): Safety and tolerability. Hypertens Res. 2015;38:132\u2013136. doi:https:\/\/doi.org\/10.1038\/hr.2014.141","journal-title":"Hypertens Res."},{"key":"5731_CR104","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/hr.2017.56","volume":"40","author":"S Tani","year":"2017","unstructured":"Tani S, Asayama K, Oiwa K, et al. The effects of increasing calcium channel blocker dose vs. adding a diuretic to treatment regimens for patients with uncontrolled hypertension. Hypertens Res. 2017;40:892\u2013898. doi:https:\/\/doi.org\/10.1038\/hr.2017.56","journal-title":"Hypertens Res."},{"key":"5731_CR105","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.2337\/dc06-1373","volume":"29","author":"G Bakris","year":"2006","unstructured":"Bakris G, Molitch M, Hewkin A, et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care. 2006;29:2592\u20132597. doi:https:\/\/doi.org\/10.2337\/dc06-1373","journal-title":"Diabetes Care."},{"key":"5731_CR106","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/jhh.2011.108","volume":"27","author":"LG Christogiannis","year":"2013","unstructured":"Christogiannis LG, Kostapanos MS, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension. J Hum Hypertens. 2013;27:44\u201350. doi:https:\/\/doi.org\/10.1038\/jhh.2011.108","journal-title":"J Hum Hypertens."},{"key":"5731_CR107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/jch.12071","volume":"15","author":"P Deedwania","year":"2013","unstructured":"Deedwania P, Shea J, Chen W, Brener L. Effects of Add-On Nebivolol on Blood Pressure and Glucose Parameters in Hypertensive Patients With Prediabetes. J Clin Hypertens. 2013;15:270\u2013278. doi:https:\/\/doi.org\/10.1111\/jch.12071","journal-title":"J Clin Hypertens."},{"key":"5731_CR108","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/hr.2015.57","volume":"38","author":"G Derosa","year":"2015","unstructured":"Derosa G, Querci F, Franzetti I, Dario Ragonesi P, D\u2019Angelo A, Maffioli P. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. Hypertens Res. 2015;38:690\u2013694. doi:https:\/\/doi.org\/10.1038\/hr.2015.57","journal-title":"Hypertens Res."},{"issue":"2","key":"5731_CR109","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jash.2011.01.006","volume":"5","author":"KC Ferdinand","year":"2011","unstructured":"Ferdinand KC, Weitzman R, Israel M, Lee J, Purkayastha D, Jaimes EA. Efficacy and safety of aliskiren-based dual and triple combination therapies in US minority patients with stage 2 hypertension. J Am Soc Hypertens. 2011;5(2):102\u2013113. doi:https:\/\/doi.org\/10.1016\/j.jash.2011.01.006","journal-title":"J Am Soc Hypertens."},{"key":"5731_CR110","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.amjhyper.2007.05.012","volume":"20","author":"R Fogari","year":"2007","unstructured":"Fogari R, Corradi L, Zoppi A, et al. Addition of manidipine improves the antihypertensive effect of candesartan hypertensive patients with type II diabetes. Am J Hypertens. 2007;20:1092\u20131096.","journal-title":"Am J Hypertens."},{"key":"5731_CR111","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1291\/hypres.31.43","volume":"31","author":"R Fogari","year":"2008","unstructured":"Fogari R, Derosa G, Zoppi A, et al. Effects of Manidipine\/Delapril versus Olmesartan\/Hydrochlorothiazide Combination Therapy in Elderly Hypertensive Patients with Type 2 Diabetes Mellitus. Hypertens Res. 2008;31:43\u201350. doi:https:\/\/doi.org\/10.1291\/hypres.31.43","journal-title":"Hypertens Res."},{"key":"5731_CR112","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","volume":"304","author":"MRC Working Party","year":"1992","unstructured":"MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results MRC Working Party. BMJ. 1992;304:405\u2013412.","journal-title":"BMJ"},{"issue":"5","key":"5731_CR113","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/0002-9343(80)90438-6","volume":"69","author":"A Helgeland","year":"1980","unstructured":"Helgeland A. Treatment of mild hypertension: A five year controlled drug trial: The Oslo study. Am J Med. 1980;69(5):725\u2013732. doi:https:\/\/doi.org\/10.1016\/0002-9343(80)90438-6","journal-title":"Am J Med."},{"key":"5731_CR114","first-page":"395","volume":"31","author":"MB Dur\u00e1n-Salgado","year":"2015","unstructured":"Dur\u00e1n-Salgado MB, Garro-Almendaro AKA, Rubio-Guerra AF. Cambios metab\u00f3licos ocasionados por las combinaciones de losart\u00e1n con hidroclorotiazida o con amlodipino en pacientes hipertensos. Med Interna Mex. 2015;31:395\u2013401.","journal-title":"Med Interna Mex."},{"issue":"10","key":"5731_CR115","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1097\/HJH.0000000000000281","volume":"32","author":"T Ogihara","year":"2014","unstructured":"Ogihara T, Saruta T, Rakugi H, et al. Combinations of olmesartan and a calciumchannel blocker or a diuretic inelderly hypertensive patients: A randomized, controlled trial. J Hypertens. 2014;32(10):2054\u20132063. doi:https:\/\/doi.org\/10.1097\/HJH.0000000000000281","journal-title":"J Hypertens."},{"key":"5731_CR116","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","unstructured":"\u201cSHEP Cooperative Research Group.\u201d Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension. JAMA. 1991;265:3255\u20133264.","journal-title":"JAMA"},{"issue":"8","key":"5731_CR117","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.1992.03480080053026","volume":"267","author":"D Siegel","year":"1992","unstructured":"Siegel D, Hulley SB, Black DM, et al. Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267(8):1083\u20131089.","journal-title":"JAMA."},{"issue":"16","key":"5731_CR118","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1001\/jama.248.16.2004","volume":"248","author":"Veterans Administration Cooperative Study Group on Antihypertensive Agents","year":"1982","unstructured":"Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA. 1982;248(16):1996\u20132003. doi:https:\/\/doi.org\/10.1001\/jama.248.16.2004","journal-title":"JAMA"},{"issue":"11","key":"5731_CR119","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/sim.1183","volume":"21","author":"P Glasziou","year":"2002","unstructured":"Glasziou P, Sanders S. Investigating causes of heterogeneity in systematic reviews. Stat Med. 2002;21(11):1503\u20131511. doi:https:\/\/doi.org\/10.1002\/sim.1183","journal-title":"Stat Med."},{"issue":"6","key":"5731_CR120","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","volume":"59","author":"MA Peterzan","year":"2012","unstructured":"Peterzan MA, Hardy R, Chaturvedi N, Hughes AD. Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate. Hypertension. 2012;59(6):1104\u20131109. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.190637","journal-title":"Hypertension."},{"issue":"6","key":"5731_CR121","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/HYPERTENSIONAHA.108.119438","volume":"52","author":"T Shafi","year":"2008","unstructured":"Shafi T, Appel LJ, Miller ER, Klag MJ, Parekh RS. Changes in serum potassium mediate thiazide-induced diabetes. Hypertension. 2008;52(6):1022\u20131029. doi:https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.108.119438","journal-title":"Hypertension."},{"issue":"11","key":"5731_CR122","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/phar.1483","volume":"34","author":"MJ Moore","year":"2014","unstructured":"Moore MJ, Gong Y, Hou W, et al. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide. Pharmacotherapy. 2014;34(11):1132\u20131140. doi:https:\/\/doi.org\/10.1002\/phar.1483","journal-title":"Pharmacotherapy."},{"issue":"5","key":"5731_CR123","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.HYP.0000125726.92964.ab","volume":"43","author":"P Verdecchia","year":"2004","unstructured":"Verdecchia P, Reboldi G, Angeli F, et al. Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects. Hypertension. 2004;43(5):963\u2013969. doi:https:\/\/doi.org\/10.1161\/01.HYP.0000125726.92964.ab","journal-title":"Hypertension."},{"key":"5731_CR124","first-page":"2926","volume":"20","author":"J Lin","year":"2016","unstructured":"Lin J., Chang H., Ku C., Chen H., Ku C. Hydrochlorothiazide hypertension treatment induced metabolic effects in type 2 diabetes: a meta-analysis of parallel-design RCTs. Eur Rev Med Pharmacol Sci. 2016;20:2926\u20132934.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"4","key":"5731_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jch.12679","volume":"18","author":"X Zhang","year":"2015","unstructured":"Zhang X, Zhao Q. Association of thiazide-type diuretics with glycemic changes in hypertensive patients: A systematic review and meta-analysis of randomized controlled clinical trials. J Clin Hypertens (Greenwich). 2015;18(4):1\u201310. doi:https:\/\/doi.org\/10.1111\/jch.12679","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"7818","key":"5731_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343(7818):1\u20138. doi:https:\/\/doi.org\/10.1136\/bmj.d4002","journal-title":"BMJ."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05731-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-020-05731-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-05731-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T12:24:42Z","timestamp":1695903882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-020-05731-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":126,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["5731"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-05731-3","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No author has any financial arrangements or potential conflicts of interest to disclose with regard to products in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}